Encorafenib plus binimetinib in patients with locally advanced, unresectable, or metastatic BRAF(V600)-mutant melanoma: Updated data from the multicenter, multinational, prospective, non-interventional longitudinal study BERING(MELANOMA)

Richtig, Erika and Loquai, Carmen and Forschner, Andrea and Gutzmer, Ralf and Hassel, Jessica Cecile and Utikal, Jochen and Haferkamp, Sebastian and Meier, Friedegund Elke and Debus, Dirk and Dummer, Reinhard and Von Moos, Roger Anton Fredy and Thompson, Jan and Gengenbacher, Laura and Michielin, Olivier and Hoeller, Christoph and Schadendorf, Dirk (2022) Encorafenib plus binimetinib in patients with locally advanced, unresectable, or metastatic BRAF(V600)-mutant melanoma: Updated data from the multicenter, multinational, prospective, non-interventional longitudinal study BERING(MELANOMA). In: Annual Meeting of the American Society of Clinical Oncology (ASCO), June 03-07, 2022, Elec Network.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (Poster)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Dermatologie und Venerologie
Depositing User:	Petra Gürster
Date Deposited:	12 Oct 2023 04:35
Last Modified:	12 Oct 2023 04:35
URI:	https://pred.uni-regensburg.de/id/eprint/58541

Actions (login required)

View Item